Akèy › Dyabèt Tip 2 › Kalifòni › Los Angeles
Etid klinik pou Dyabèt Tip 2 nan Los Angeles, CA
16 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Ap rekriteFaz 3
- Downtown LA Res Ctr. Inc., Los Angeles
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Inglewood Clinical, Los Angeles
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Los Angeles
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Ap rekriteFaz 2
- Los Angeles Institute for Metabolic Research, Los Angeles
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- Los Angeles Institute for Metabolic Research, Los Angeles
- Velocity Clinical Research, Los Angeles, Los Angeles
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Ap rekriteFaz 3
- VAGLAHS Clinical Research Center (CRC), Los Angeles
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Los Angeles
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Ap rekriteFaz 3
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Ap rekrite
- University of Southern California, Los Angeles
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Ap rekrite
- University of Southern California, Los Angeles
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Ap rekriteEtid obsèvasyon
- Children's Hospital Los Angeles, Los Angeles
Type 2 Continuous Glucose Monitoring Academy
Ap rekrite
- Children's Hospital Los Angeles, Los Angeles
New T-UP: Engaging Vulnerable Students in Diabetes Prevention
Ap rekrite
- University of California, Los Angeles, Los Angeles
Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Ap rekrite
- Children's Hospital Los Angeles, Los Angeles
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
Ap rekrite
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
DETERMINE: Detemir vs NPH
Ap rekriteFaz 2
- University of California, Los Angeles, Los Angeles
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL25 etid
- Boston, MA20 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Miami, FL19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- San Diego, CA17 etid
- Atlanta, GA17 etid
- Birmingham, AL16 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.